Hepatitis B prevention interventions during HIV post-exposure prophylaxis visits: A retrospective chart review
International Journal of STD & AIDS · 2025
DOI: 10.1177/09564624251325312 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Emma B Monti und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Queen's University, Kingston, ON, Canada. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis B, Post-Exposure Prophylaxis, Hepatitis B Vaccines. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Tier 2 Canada Research Chair in HIV Prevention and STI Research.
Abstract (Originalsprache)
Background
Hepatitis B virus (HBV) disproportionately affects people at risk of HIV. Encounters for HIV post-exposure prophylaxis (PEP) create opportunities for HBV screening and prevention. We quantified HBV prevalence, susceptibility, and active/passive immunization use among patients seeking HIV PEP.
Methods
We conducted a retrospective chart review of patients requesting PEP at an academic hospital between 2001-2021 in Toronto, Canada. Patients were classified as HBV immune or susceptible based on laboratory tests. Among HBV-susceptible individuals, we quantified how often HBV vaccine and/or hepatitis B immune globulin (HBIG) were administered.
Results
We identified 2018 PEP episodes, 75.3% being for sexual exposures. Mean age was 33.6 years. Among 1593 (78.9%) participants with available HBV testing data, six (0.4%) tested HBsAg-positive. Of 2018 episodes, 56.8% were among HBV-immune and 19.8% among HBV-susceptible participants; 23.1% were among participants of unknown status. Of susceptible participants, 55 (13.8%) received HBIG and 143 (35.8%) received HBV vaccinations.
Conclusions
HBV prevalence was low but roughly one-fifth of patients seeking HIV PEP were HBV-susceptible. HBIG use was inconsistent with current guidelines, and a minority of HBV-susceptible individuals were vaccinated. More systematic HBV testing, increased HBV vaccination and more rational use of HBIG are needed in those seeking HIV PEP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Queen's University, Kingston, ON, Canada.
- Integrated Program in Neuroscience, McGill University, Montréal, QC, Canada.
- MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada.
- Division of Infectious Diseases, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
- Department of Pharmacy, St. Michael's Hospital, Toronto, ON, Canada.
- Department of Medicine, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Emma B Monti, Monica Rudd, Darrell Hs Tan
Förderung
- Tier 2 Canada Research Chair in HIV Prevention and STI Research
Zitieren
APA
Monti, E. B., Penichet, D., Rudd, M., Yoong, D., Pathan, S. S., Moin, A., Myers, S. A., & Tan, D. H. (2025). Hepatitis B prevention interventions during HIV post-exposure prophylaxis visits: A retrospective chart review. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251325312
Vancouver
Monti EB, Penichet D, Rudd M, Yoong D, Pathan SS, Moin A, et al. Hepatitis B prevention interventions during HIV post-exposure prophylaxis visits: A retrospective chart review. International Journal of STD & AIDS. 2025. doi:10.1177/09564624251325312
BibTeX
@article{Monti2025,
author = {Monti, Emma B and Penichet, Danae and Rudd, Monica and Yoong, Deborah and Pathan, Sara S and Moin, Asma and Myers, Samantha A and Tan, Darrell Hs},
title = {Hepatitis B prevention interventions during HIV post-exposure prophylaxis visits: A retrospective chart review},
journal = {International Journal of STD & AIDS},
year = {2025},
doi = {10.1177/09564624251325312}
}
EUVIMED